FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nina Anensen

Research Profile

Chemicals & Drugs

Disorders

Procedures

Physiology

Phenomena

Acetylation

Occupations

Proteomics

Co-author Network

Publications

TOP 3
Nina Anensen; Oystein Bruserud; J-C Bourdon; Ingvild Haaland; S M Hjelle; Randi Hovland; Stian Knappskog; Per Eystein Lønning; E Silden; K Taskén; Werner Van Belle; Bjorn T Gjertsen
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.
Elisabeth Ersvaer; Jian-Ying Zhang; Emmet McCormack; Astrid Olsnes; Nina Anensen; Eng M Tan; Bjorn T Gjertsen; Oystein Bruserud
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
Nina Anensen; Anne Margrete Øyan; Sjur Huseby; Karl-Henning Kalland; Øystein Bruserud; Bjorn T Gjertsen
Early gene expression of acute myeloid leukemia in response to chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nina Anensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nina Anensen; Oystein Bruserud; J-C Bourdon; Ingvild Haaland; S M Hjelle; Randi Hovland; Stian Knappskog; Per Eystein Lønning; E Silden; K Taskén; Werner Van Belle; Bjorn T Gjertsen
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.
Oncogene 2012;31(12):1533-45.
2007: Elisabeth Ersvaer; Jian-Ying Zhang; Emmet McCormack; Astrid Olsnes; Nina Anensen; Eng M Tan; Bjorn T Gjertsen; Oystein Bruserud
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
European journal of haematology 2007;79(3):210-25.
2007: Nina Anensen; Anne Margrete Øyan; Sjur Huseby; Karl-Henning Kalland; Øystein Bruserud; Bjorn T Gjertsen
Early gene expression of acute myeloid leukemia in response to chemotherapy.
Expert review of anticancer therapy 2007;7(5):741-51.
2007: Jonathan Irish; Nina Anensen; Randi Hovland; Jørn Skavland; Anne-Lise Børresen-Dale; Oystein Bruserud; Garry P Nolan; Bjorn T Gjertsen
Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Blood 2007;109(6):2589-96.
2006: Werner Van Belle; Gry Sjøholt; Nina Anensen; Kjell-Arild Høgda; Bjorn T Gjertsen
Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment.
Electrophoresis 2006;27(20):4086-95.
2006: Nina Anensen; Anne Margrete Oyan; Jean-Christophe Bourdon; Karl-Henning Kalland; Oystein Bruserud; Bjorn T Gjertsen
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3985-92.
2006: Nina Anensen; Ingvild Haaland; Clive D'Santos; Werner Van Belle; Bjorn T Gjertsen
Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.
Current pharmaceutical biotechnology 2006;7(3):199-207.
2006: Nina Anensen; Jørn Skavland; Camilla Stapnes; Anita Ryningen; A-L Børresen-Dale; Bjorn T Gjertsen; Øystein Bruserud
Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report.
Leukemia 2006;20(4):734-6.
2006: Øystein Bruserud; Camilla Stapnes; Karl Johan Tronstad; Anita Ryningen; Nina Anensen; Bjorn T Gjertsen
Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.
Expert opinion on therapeutic targets 2006;10(1):51-68.
2006: Werner Van Belle; Nina Anensen; Ingvild Haaland; Øystein Bruserud; Kjell-Arild Høgda; Bjorn T Gjertsen
Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables.
BMC bioinformatics 2006;7():198.
2005: Gry Sjøholt; Nina Anensen; Line Wergeland; Emmet Mc Cormack; Øystein Bruserud; Bjorn T Gjertsen
Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.
Current drug targets 2005;6(6):631-46.